How Much Did Cymulate Raise?
Funding & Key Investors

Cymulate, a provider of SaaS-based breach and attack simulation platforms, has secured significant enterprise-level funding, with its total funding amount reaching $137.5M. The company recently announced a major strategic investment of $70M, underscoring its continued growth and market traction in the cybersecurity sector. This latest capital infusion is expected to fuel further development and expansion of its exposure management solutions.

What is Cymulate?

Cymulate
SoftwareSecurity Software

Founded in 2016, Cymulate offers a comprehensive SaaS-based breach and attack simulation platform designed to help organizations proactively identify and remediate security vulnerabilities. By simulating real-world cyber threats, Cymulate provides actionable insights into an organization's exposure, enabling them to strengthen their defenses. The company operates within the rapidly evolving cybersecurity landscape, where continuous assessment and adaptation are critical for maintaining robust security postures against sophisticated threats.

How much funding has Cymulate raised?

Cymulate has raised a total of $137.5M across 4 funding rounds:

2019

Series A

$7.5M

Series B

$15M

2021

Series C

$45M

2022

Series D

$70M

Series A (2019): $7.5M, investors not publicly disclosed

Series B (2019): $15M led by Dell, Vertex Growth Fund, Susquehanna Growth Equity, and Vertex Ventures Israel

Series C (2021): $45M supported by Vertex Ventures, One Peak Partners, Vertex Growth Fund, Dell Technologies Capital, and Susquehanna Growth Equity

Series D (2022): $70M featuring Susquehanna Growth Equity, Dell Technologies Capital, Vertex Ventures, and One Peak Partners

Key Investors in Cymulate

Vertex Ventures

Vertex Ventures US is an early-stage venture capital firm that supports founders creating a smarter digital economy through B2B software. They focus on partnering with and investing in early-stage infrastructure and SaaS companies, leveraging their experience as former founders and operators.

Susquehanna Growth Equity

Susquehanna Growth Equity is a growth equity fund focused on software, SaaS, data, internet, healthcare technology, and financial technology. The company is headquartered in Bala Cynwyd, Pennsylvania.

Dell Technologies Capital

Dell Technologies Capital is a venture investment team that focuses on early-stage investments in companies developing innovative enterprise technologies, primarily in sectors such as cybersecurity, AI/ML, and data analytics.

What's next for Cymulate?

With its recent major strategic investment and substantial overall funding, Cymulate is well-positioned for accelerated growth. The company is likely to leverage this capital to enhance its platform capabilities, expand its market reach, and potentially pursue strategic partnerships or acquisitions. Continued investment in R&D will be crucial for staying ahead of emerging cyber threats and maintaining its competitive edge in the breach and attack simulation market. The company's trajectory suggests a focus on scaling its operations and solidifying its position as a leader in proactive cybersecurity solutions.

See full Cymulate company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftwareHealthcare ServicesMental Health & Rehabilitation FacilitiesMobile App Development
Security SoftwareSoftwareBusiness ServicesSoftware Testing
Financial SoftwareSoftwareEngineering Software
Business Intelligence (BI) SoftwareSoftwareBusiness ServicesSoftware Testing

Frequently Asked Questions Regarding Cymulate Financial Insights

What are the most recent funding rounds that Cymulate has completed, and what were the funding rounds?
Cymulate has recently completed 3 funding rounds: Series D on Sep 6, 2022, Series C on May 5, 2021, Series B on Nov 26, 2019.
What is the total amount of funding Cymulate has raised to date?
Cymulate has raised a total of $137.5M in funding to date.
How many funding rounds has Cymulate completed?
Cymulate has completed 3 funding rounds.
How much funding did Cymulate raise in its most recent funding round?
Cymulate raised $70M in its most recent funding round.
Who are the lead investors in Cymulate's latest funding round?
The lead investor in Cymulate's latest funding round was Susquehanna Growth Equity. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Cymulate's history?
The largest funding round in Cymulate's history was $70M.
See more information about Cymulate